May 24, 2022
The new IGX-Track App adds seamless analysis of antibody panning campaigns to the IGX Platform 's-Hertogenbosch, The Netherlands – ENPICOM, an innovative bioinformatics software company, announced the upcoming expansion of the capabilities of the IGX Platform to unlock seamless analysis of antibody panning data. This major development will allow researchers to analyze antibody display data [...]
Illumina Ventures Announces Promotion and Additions to its Investment Team
May 24, 2022
FOSTER CITY, Calif. -- Illumina Ventures, today announced the promotion of Malek Faham, MD, PhD, to Chief Scientist having previously served as both a Venture Partner and Entrepreneur in Residence (EIR). In addition, Charles Lin, PhD, has joined the team as a Principal, and Dave Johnson, PhD, has joined as an Entrepreneur in Residence. “Having [...]
CN Bio Appoints Dr Paul Brooks as Chief Business Officer
May 24, 2022
CAMBRIDGE, England -- CN Bio, a leading Organ-on-a-chip Company (OOC) that designs and manufactures single- and multi-organ microphysiological systems (MPS), today announced the appointment of Dr Paul Brooks as Chief Business Officer. Key to the next stage of the Company’s growth, Paul will be responsible for shaping the company’s commercial business strategy and leading the [...]
May 24, 2022
Granted by the United States Patent and Trademark Office, with extensions filed globally, the patent covers an approach that gives laboratories the ability to increase productivity for time and cost efficiencies. GOTHENBURG, Sweden -- Biosero, Inc., a BICO company and developer of laboratory automation solutions to orchestrate scientific discoveries, announced the issuance of a key patent underlying its [...]
Alithea Genomics Raises CHF 1 Million in Seed Financing Round led by Novalis Biotech
May 24, 2022
Proceeds to Enable Commercialization and Scale-Up of Unique RNA Sequencing Technology. Lausanne, Switzerland – Alithea Genomics, a fast-growing, emerging leader in the field of RNA sequencing and transcriptomics analysis, announced today the closing of a CHF 1 million seed financing round led by the Novalis Biotech Acceleration fund, with participation of Swiss-based private investors. Alithea has developed [...]
MIP Discovery Adopts the Fida 1 Platform
May 24, 2022
The FIDA technology enables MIP Discovery to offer Molecularly Imprinted Polymers of unmatched quality. BEDFORD, BEDFORDSHIRE, UNITED KINGDOM -- MIP Discovery today announced the adoption of the Fida 1 platform into it’s library of analytical techniques for the characterization of Molecularly Imprinted Polymers. Molecularly Imprinted Polymers (MIPs) are animal free alternatives to antibodies that are completely synthetic and extremely robust. Used [...]
May 23, 2022
GeoMx NextSeq workflow creates a streamlined end-to-end solution for spatial multiomic analysis, reducing user touchpoints, and the need for on-site informatics infrastructure SEATTLE -- NanoString Technologies, Inc. (NASDAQ: NSTG), a leading provider of life science tools for discovery and translational research, today announced a seamless, cloud-based workflow that improves the spatial data analysis experience of [...]
Qlucore adds another cancer diagnostics area
May 23, 2022
- Cooperates with scientists from Lund University to develop improved bladder cancer diagnostics Qlucore – listed on Nasdaq First North – is delighted to announce a new collaboration in the field of precision diagnostics to develop solutions for improved clinical diagnostics of bladder cancer. Bladder cancer is the third classifier model co-operation launched by Qlucore in [...]
Emanuel Merck Lectureship 2022 Awarded to John F. Hartwig
May 23, 2022
The Emanuel Merck Lectureship was jointly established by Merck and TU Darmstadt in 1992. It recognizes globally renowned scientists who have made superb contributions to chemical and pharmaceutical research. DARMSTADT, GERMANY Outstanding scientific work in the field of metallo-organic chemistry honored Co-discoverer of the Buchwald-Hartwig amination 17th joint award presented by TU Darmstadt and Merck Merck, [...]
Element Appoints Mark Aitkenhead, PhD, as Chief Commercial Officer
May 23, 2022
Element Biosciences Inc., developer of the Element AVITI™ System, a new and disruptive DNA sequencing platform, today announced the appointment of Mark Aitkenhead, PhD, as Chief Commercial Officer. In this role, Dr. Aitkenhead will build, guide, and manage the customer-facing functions of the company, including sales, marketing, customer support, and training. As a member of the executive leadership [...]

